← 홈

Antibody

136개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 136개
AntibodystaleRochePhase 3

HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab (HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 3

HR070803 simulator plus oxaliplatin, 5-FU/LV, bevacizumab (HR070803 simulator plus oxaliplatin, 5-FU/LV, bevacizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleTaizhou Hanzhong biomedical co.…Phase 3

Pucotenlimab (HX008, HX008(Pucotenlimab))

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleSecond Affiliated Hospital, Sch…Phase 2

IBI351, cetuximab β combined with FOLFIRI (IBI351, cetuximab β combined with FOLFIRI)

Colorectal Cancer Metastatic; KRAS G12C Mutation · Colorectal Cancer Metastatic

#ColorectalCancerMetastatic#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 3

Imprime PGG + cetuximab (Imprime PGG + cetuximab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleEli LillyPhase 2

Irinotecan Liposomes (II, Irinotecan Liposomes, Irinotecan Liposomes (II)+Cetuximab+Bevacizumabl)

Colorectal Cancer Metastatic · Colorectal Cancer Metastatic

#ColorectalCancerMetastatic#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleThe Fourth Affiliated Hospital …Phase 2

Irinotecan liposome combined with capecitabine, bevacizumab and camrelizumab (Irinotecan liposome combined with capecitabine, bevacizumab and camrelizumab)

Metastatic Colorectal Cancer (CRC) · Metastatic Colorectal Cancer (CRC)

#MetastaticColorectalCancerCRC#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleGruppo Italiano per lo studio d…Phase 3

Irinotecan/Cetuximab (Irinotecan/Cetuximab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleKeythera Pharmaceuticals (Austr…Phase 1

atezolizumab (Tecentriq, KF-0210, KF-0210 (dosage RP2D) + Atezolizumab, dosage RP2D)

Advanced Solid Tumor; Colorectal Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleKeythera Pharmaceuticals (Austr…Phase 1

atezolizumab (Tecentriq, KF-0210, dosage RP2D-1, KF-0210 (dosage RP2D-1) + Atezolizumab)

Advanced Solid Tumor; Colorectal Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleKeythera Pharmaceuticals (Austr…Phase 1

atezolizumab (Tecentriq, KF-0210, dosage RP2D-2, KF-0210 (dosage RP2D-2) + Atezolizumab)

Advanced Solid Tumor; Colorectal Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleThe First Hospital of Jilin Uni…Phase 2

Levofolinic Acid + 5-FU continuous infusion + irinotecan HCl liposome ± cetuximab/bevacizumab (Levofolinic Acid + 5-FU continuous infusion + irinotecan HCl liposome ± cetuximab/bevacizumab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleMerus B.V.Phase 2

pembrolizumab (Keytruda, MCLA-158 + Pembrolizumab)

Advanced/Metastatic Solid Tumors; Colorectal Cancer · Advanced/Metastatic Solid Tumors

#AdvancedMetastaticSolidTumors#Antibody#Phase2#항체#면역항체+5
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab (Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab)

Refractory Metastatic Colorectal Cancer · FRα

#FR#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleAustralasian Gastro-Intestinal …Phase 3

Mitomycin C; Capecitabine; Bevacizumab (Mitomycin C; Capecitabine; Bevacizumab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

NUC-3373 + bevacizumab (NUC-3373 + bevacizumab)

Colorectal Cancer; Colorectal Neoplasms · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 1

Nilotinib + Cetuximab (Nilotinib + Cetuximab)

Colorectal Cancer; Head and Neck Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 3

OPTIMOX-bevacizumab (OPTIMOX-bevacizumab)

Elderly Patients; Metastatic Colorectal Cancer · Elderly Patients

#ElderlyPatients#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleShanghai Pudong HospitalPhase 2

Ongericimab + Toripalimab + Bevacizumab + FOLFIRI (Ongericimab + Toripalimab + Bevacizumab + FOLFIRI)

Advanced Colorectal Cancer · Advanced Colorectal Cancer

#AdvancedColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleShanghai Pudong HospitalPhase 2

Ongericimab + Toripalimab + Bevacizumab + FOLFOX (Ongericimab + Toripalimab + Bevacizumab + FOLFOX)

Advanced Colorectal Cancer · Advanced Colorectal Cancer

#AdvancedColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING

5 / 7 페이지

← 이전다음 →